Published in J Neurogastroenterol Motil on December 30, 2013
Intestinal microbiota and diet in IBS: causes, consequences, or epiphenomena? Am J Gastroenterol (2015) 1.13
Small Intestinal Bacterial Overgrowth in Patients with Refractory Functional Gastrointestinal Disorders. J Neurogastroenterol Motil (2016) 0.88
Irritable Bowel Syndrome, Particularly the Constipation-Predominant Form, Involves an Increase in Methanobrevibacter smithii, Which Is Associated with Higher Methane Production. Gut Liver (2016) 0.86
Review article: inhibition of methanogenic archaea by statins as a targeted management strategy for constipation and related disorders. Aliment Pharmacol Ther (2015) 0.79
Breath Methane Levels Are Increased Among Patients with Diverticulosis. Dig Dis Sci (2016) 0.76
Biomarkers of Irritable Bowel Syndrome. J Neurogastroenterol Motil (2016) 0.75
Modeling of breath methane concentration profiles during exercise on an ergometer. J Breath Res (2016) 0.75
Lactulose Breath Test Gas Production in Childhood IBS is Associated with Intestinal Transit and Bowel Movement Frequency. J Pediatr Gastroenterol Nutr (2016) 0.75
Gastrointestinal neuromuscular apparatus: An underestimated target of gut microbiota. World J Gastroenterol (2016) 0.75
Neuromodulatory effects and targets of the SCFAs and gasotransmitters produced by the human symbiotic microbiota. Microb Ecol Health Dis (2016) 0.75
Additional Value of CH₄ Measurement in a Combined (13)C/H₂ Lactose Malabsorption Breath Test: A Retrospective Analysis. Nutrients (2015) 0.75
Gut Colonization by Methanogenic Archaea Is Associated with Organic Dairy Consumption in Children. Front Microbiol (2017) 0.75
Mechanisms of Action of Probiotics and the Gastrointestinal Microbiota on Gut Motility and Constipation. Adv Nutr (2017) 0.75
Therapeutic Modulation of Gut Microbiota in Functional Bowel Disorders. J Neurogastroenterol Motil (2017) 0.75
Response of irritable bowel syndrome with constipation patients administered a combined quebracho/conker tree/M. balsamea Willd extract. World J Gastrointest Pharmacol Ther (2016) 0.75
Recent Updates on the Treatment of Constipation. Intest Res (2015) 0.75
Potential of in vivo real-time gastric gas profiling: a pilot evaluation of heat-stress and modulating dietary cinnamon effect in an animal model. Sci Rep (2016) 0.75
Excessive alcohol consumption induces methane production in humans and rats. Sci Rep (2017) 0.75
Methanobrevibacter attenuation via probiotic intervention reduces flatulence in adult human: A non-randomised paired-design clinical trial of efficacy. PLoS One (2017) 0.75
Diversity of the human intestinal microbial flora. Science (2005) 49.64
Development of the human infant intestinal microbiota. PLoS Biol (2007) 18.91
Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med (2011) 10.03
Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci U S A (2010) 9.57
The functional gastrointestinal disorders and the Rome III process. Gastroenterology (2006) 8.71
Methanogens and the diversity of archaebacteria. Microbiol Rev (1987) 7.77
Lactulose breath testing does not discriminate patients with irritable bowel syndrome from healthy controls. Am J Gastroenterol (2008) 3.95
Factors influencing pulmonary methane excretion in man. An indirect method of studying the in situ metabolism of the methane-producing colonic bacteria. J Exp Med (1971) 3.88
Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. a double-blind, randomized, placebo-controlled study. Am J Gastroenterol (2003) 3.84
The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial. Ann Intern Med (2006) 3.30
Enumeration of Methanobrevibacter smithii in human feces. Arch Microbiol (1982) 2.78
Methanogenic Archaea and human periodontal disease. Proc Natl Acad Sci U S A (2004) 2.68
Production, metabolism, and excretion of hydrogen in the large intestine. Gastroenterology (1992) 2.34
Incidence of methanogenic bacteria in a sigmoidoscopy population: an association of methanogenic bacteria and diverticulosis. Gut (1986) 2.13
High prevalence of Methanobrevibacter smithii and Methanosphaera stadtmanae detected in the human gut using an improved DNA detection protocol. PLoS One (2009) 2.05
Methanogenic flora is associated with altered colonic transit but not stool characteristics in constipation without IBS. Am J Gastroenterol (2009) 1.96
Methane, a gas produced by enteric bacteria, slows intestinal transit and augments small intestinal contractile activity. Am J Physiol Gastrointest Liver Physiol (2005) 1.96
Breath-methane in patients with cancer of the large bowel. Lancet (1977) 1.89
Methane excretion in man--a study of breath, flatus, and faeces. Gut (1985) 1.88
Evaluation of gastrointestinal transit in clinical practice: position paper of the American and European Neurogastroenterology and Motility Societies. Neurogastroenterol Motil (2011) 1.72
A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence. Am J Gastroenterol (2006) 1.67
Human methanogen diversity and incidence in healthy and diseased colonic groups using mcrA gene analysis. BMC Microbiol (2008) 1.56
Cesarean versus vaginal delivery: long-term infant outcomes and the hygiene hypothesis. Clin Perinatol (2011) 1.52
Relationships between hydrogen (H2) and methane (CH4) production in man. Scand J Gastroenterol (1982) 1.51
Small intestinal bacterial overgrowth in gastroparesis. Dig Dis Sci (2012) 1.49
Stability of human methanogenic flora over 35 years and a review of insights obtained from breath methane measurements. Clin Gastroenterol Hepatol (2006) 1.47
Methane production during lactulose breath test is associated with gastrointestinal disease presentation. Dig Dis Sci (2003) 1.46
The degree of breath methane production in IBS correlates with the severity of constipation. Am J Gastroenterol (2007) 1.46
The effect of age, sex and level of intake of dietary fibre from wheat on large-bowel function in thirty healthy subjects. Br J Nutr (1986) 1.44
Rome III functional constipation and irritable bowel syndrome with constipation are similar disorders within a spectrum of sensitization, regulated by serotonin. Gastroenterology (2013) 1.27
Results of small intestinal bacterial overgrowth testing in irritable bowel syndrome patients: clinical profiles and effects of antibiotic trial. Adv Med Sci (2007) 1.26
Pyxigraphic sampling to enumerate methanogens and anaerobes in the right colon of healthy humans. Gastroenterology (1993) 1.26
Methane and the gastrointestinal tract. Dig Dis Sci (2009) 1.24
Role of dietary sulphate in the regulation of methanogenesis in the human large intestine. Gut (1992) 1.24
Neomycin improves constipation-predominant irritable bowel syndrome in a fashion that is dependent on the presence of methane gas: subanalysis of a double-blind randomized controlled study. Dig Dis Sci (2006) 1.24
Shared and unique environmental factors determine the ecology of methanogens in humans and rats. Am J Gastroenterol (2000) 1.21
Relations between transit time, fermentation products, and hydrogen consuming flora in healthy humans. Gut (1996) 1.20
Breath hydrogen response to lactulose in healthy subjects: relationship to methane producing status. Gut (1990) 1.20
The importance of methane breath testing: a review. J Breath Res (2013) 1.19
Evolution of the Archaea. Theor Popul Biol (2002) 1.13
Intestinal gas in plain abdominal radiographs does not correlate with symptoms after lactulose challenge. Eur J Gastroenterol Hepatol (2007) 1.12
Metabolism of methanogens. Antonie Van Leeuwenhoek (1994) 1.11
Bacterial, archaeal, and eukaryal diversity in the intestines of Korean people. J Microbiol (2008) 1.09
Carbohydrates and the human gut microbiota. Curr Opin Clin Nutr Metab Care (2013) 1.08
Evaluating breath methane as a diagnostic test for constipation-predominant IBS. Dig Dis Sci (2009) 1.06
Methanobrevibacter smithii is the predominant methanogen in patients with constipation-predominant IBS and methane on breath. Dig Dis Sci (2012) 1.04
Factors affecting methane production in humans. Gastrointestinal diseases and alterations of colonic flora. Dig Dis Sci (1987) 1.04
Relationship between intestinal gas and the development of right colonic diverticula. J Neurogastroenterol Motil (2010) 1.02
Methane on breath testing is associated with constipation: a systematic review and meta-analysis. Dig Dis Sci (2011) 1.02
The role of methane in intestinal diseases. Am J Gastroenterol (2010) 0.98
The effects of methane and hydrogen gases produced by enteric bacteria on ileal motility and colonic transit time. Neurogastroenterol Motil (2011) 0.97
Methane and hydrogen positivity on breath test is associated with greater body mass index and body fat. J Clin Endocrinol Metab (2013) 0.97
Methane and hydrogen production by human intestinal anaerobic bacteria. Acta Pathol Microbiol Immunol Scand B (1982) 0.97
Small intestinal bacterial overgrowth in irritable bowel syndrome: association with colon motility, bowel symptoms, and psychological distress. Neurogastroenterol Motil (2008) 0.96
A versatile medium for cultivating methanogenic archaea. PLoS One (2013) 0.96
Breath methane excretion and intestinal methanogenesis in children and adults in rural Nigeria. Scand J Gastroenterol (1993) 0.94
Comparative study of hydrogen and methane production in the human colon using caecal and faecal homogenates. Gut (1990) 0.94
Small intestinal bacterial overgrowth in irritable bowel syndrome: are there any predictors? BMC Gastroenterol (2010) 0.94
Reassessment of the role of methane production between irritable bowel syndrome and functional constipation. J Gastrointestin Liver Dis (2012) 0.93
Slow transit constipation associated with excess methane production and its improvement following rifaximin therapy: a case report. J Neurogastroenterol Motil (2011) 0.91
A combination of rifaximin and neomycin is most effective in treating irritable bowel syndrome patients with methane on lactulose breath test. J Clin Gastroenterol (2010) 0.90
Methane production and small intestinal bacterial overgrowth in children living in a slum. World J Gastroenterol (2012) 0.89
Incidence of predominant methanogenic flora in irritable bowel syndrome patients and apparently healthy controls from North India. Dig Dis Sci (2008) 0.88
Assessment of symptoms during gastric emptying scintigraphy to correlate symptoms to delayed gastric emptying. Neurogastroenterol Motil (2010) 0.88
Small intestinal bacterial overgrowth in gastroparesis: are there any predictors? J Clin Gastroenterol (2010) 0.87
Susceptibility of archaea to antimicrobial agents: applications to clinical microbiology. Clin Microbiol Infect (2012) 0.87
Breath methane positivity is more common and higher in patients with objectively proven delayed transit constipation. Eur J Gastroenterol Hepatol (2013) 0.86
Association between symptoms of irritable bowel syndrome and methane and hydrogen on lactulose breath test. J Korean Med Sci (2013) 0.85
Pulmonary hydrogen and methane excretion following ingestion of an unabsorbable carbohydrate: a study of twins. J Pediatr Gastroenterol Nutr (1985) 0.85
IBS subjects with methane on lactulose breath test have lower postprandial serotonin levels than subjects with hydrogen. Dig Dis Sci (2004) 0.84
Carbohydrate malabsorption: quantification by methane and hydrogen breath tests. Scand J Gastroenterol (1994) 0.83
The domain Archaea in human mucosal surfaces. Clin Microbiol Infect (2012) 0.81
The characteristics of the positivity to the lactulose breath test in patients with abdominal bloating. Eur J Gastroenterol Hepatol (2011) 0.81
Factor analysis demonstrates a symptom cluster related to methane and non-methane production in irritable bowel syndrome. J Clin Gastroenterol (2011) 0.81
Methane production and bowel function parameters in healthy subjects on low- and high-fiber diets. Nutr Cancer (1991) 0.78
Relationship between methane production and breath hydrogen excretion in lactose-malabsorbing individuals. Dig Dis Sci (1993) 0.77
Milk-induced malabsorption in malnourished African patients. Am J Clin Nutr (1991) 0.76
Biomarkers of Irritable Bowel Syndrome. J Neurogastroenterol Motil (2016) 0.75
Repeat treatment with rifaximin improves irritable bowel syndrome-related quality of life: a secondary analysis of a randomized, double-blind, placebo-controlled trial. Therap Adv Gastroenterol (2017) 0.75
Is small intestinal bacterial overgrowth involved in the pathogenesis of functional dyspepsia? Med Hypotheses (2017) 0.75